Mashal M. Alshazi, B.Pharm, PhD
Assistant Professor of Pharmaceutical Biotechnology, College of Pharmacy and the Research Chair of Vaccines for Infectious Diseases, King Saud University
Mashal M. Alshazi earned his bachelor degree in Pharmaceutical Sciences from King Saud University in 2006 and his Ph.D. in Pharmaceutical Biotechnology from the University of Illinois, USA in 2015. During 2014, he joined AstraZeneca, Infection BioScience, Boston, where he worked in development of in-depth pharmacokinetic/pharmacodynamics (PK/PD) profiles of drugs against clinical isolates using in vitro hollow fiber infection model. During 2017-2018, he joined a fellowship program at Department of Pediatrics National School of Tropical Medicine, Baylor College of Medicine and Texas Children’s Hospital Center for Vaccine Development – Product Development Partnership. During his time at Center for Vaccine Development, he participated in development of vaccines against MERS-CoV and leishmaniasis. He was trained at different vaccines and biologics units including discovery unit, process development unit (upstream and downstream processes), formulation and analytical unit and quality control and quality assurance units. Dr. Alshazi is having several research grants from Saudi Ministry of Education (MOE), Ministry of National Guard, Saudi Ministry of Health (MOH) and King Saud University (KSU) for development of RNA and protein based vaccines against MERS and COVID19. Currently, Dr. Alshazi is working as assistant professor of pharmaceutical biotechnology at College of Pharmacy, KSU. Since 2011, Dr. Alshazi authored and co-authored several peer-reviewed articles, and supervised, co-supervised and examined a number of undergraduate and graduate students. Dr. Alshazi has authored many standard operating procedures based on FDA and EMA regulations. He is a reviewer and editor for many reputable journals. He has organized conferences in the region related to vaccines and biologics with invited speakers from Europe and the United States. He received several awards including Grand Challenges grant Award in 2020 and Van Doren Scholar Award in 2015. Dr. Alshazi interests include pharmaceutical and biopharmaceutical R&D, industry and regulation especially in the fields of vaccines, biologics and biosimilars. Dr. Mashal is working with several bodies as vaccines and biologics consultant including Saudi Food and Drug Authority (SFDA).